Examining Evolving Treatment Paradigms in the Hemophilia B Space

Steven Pipe, MD, defines Hemophilia B and its standard of care.

Dr Steven Pipe delves into the economic burden associated with Hemophilia B treatment, including costs and payer considerations.

A hematologic expert explains the role gene therapy might play with Hemophilia B.

Dr Pipe discusses the impact of gene therapy in the Hemophilia B landscape, for both the payer and patient.

Steven Pipe, MD, describes his hopes for Hemophilia B treatment in the future.